224 related articles for article (PubMed ID: 22927638)
21. Paradoxical instability-activity relationship defines a novel regulatory pathway for retinoblastoma proteins.
Acharya P; Raj N; Buckley MS; Zhang L; Duperon S; Williams G; Henry RW; Arnosti DN
Mol Biol Cell; 2010 Nov; 21(22):3890-901. PubMed ID: 20861300
[TBL] [Abstract][Full Text] [Related]
22. E2F/DP Prevents Cell-Cycle Progression in Endocycling Fat Body Cells by Suppressing dATM Expression.
Guarner A; Morris R; Korenjak M; Boukhali M; Zappia MP; Van Rechem C; Whetstine JR; Ramaswamy S; Zou L; Frolov MV; Haas W; Dyson NJ
Dev Cell; 2017 Dec; 43(6):689-703.e5. PubMed ID: 29233476
[TBL] [Abstract][Full Text] [Related]
23. Suppression of the rbf null mutants by a de2f1 allele that lacks transactivation domain.
Du W
Development; 2000 Jan; 127(2):367-79. PubMed ID: 10603353
[TBL] [Abstract][Full Text] [Related]
24. Rbf1 degron dysfunction enhances cellular DNA replication.
Raj N; Zhang L; Wei Y; Arnosti DN; Henry RW
Cell Cycle; 2012 Oct; 11(20):3731-8. PubMed ID: 22895052
[TBL] [Abstract][Full Text] [Related]
25. DNA-binding and trans-activation properties of Drosophila E2F and DP proteins.
Dynlacht BD; Brook A; Dembski M; Yenush L; Dyson N
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6359-63. PubMed ID: 8022787
[TBL] [Abstract][Full Text] [Related]
26. The pro-apoptotic activity of Drosophila Rbf1 involves dE2F2-dependent downregulation of diap1 and buffy mRNA.
Clavier A; Baillet A; Rincheval-Arnold A; Coléno-Costes A; Lasbleiz C; Mignotte B; Guénal I
Cell Death Dis; 2014 Sep; 5(9):e1405. PubMed ID: 25188515
[TBL] [Abstract][Full Text] [Related]
27. A genetic screen for modifiers of E2F in Drosophila melanogaster.
Staehling-Hampton K; Ciampa PJ; Brook A; Dyson N
Genetics; 1999 Sep; 153(1):275-87. PubMed ID: 10471712
[TBL] [Abstract][Full Text] [Related]
28. A B-myb promoter corepressor site facilitates in vivo occupation of the adjacent E2F site by p107 x E2F and p130 x E2F complexes.
Catchpole S; Tavner F; Le Cam L; Sardet C; Watson RJ
J Biol Chem; 2002 Oct; 277(41):39015-24. PubMed ID: 12147683
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
[TBL] [Abstract][Full Text] [Related]
30. Mosaic genetic screen for suppressors of the de2f1 mutant phenotype in Drosophila.
Ambrus AM; Rasheva VI; Nicolay BN; Frolov MV
Genetics; 2009 Sep; 183(1):79-92. PubMed ID: 19546319
[TBL] [Abstract][Full Text] [Related]
31. Context-dependent requirement for dE2F during oncogenic proliferation.
Nicolay BN; Frolov MV
PLoS Genet; 2008 Oct; 4(10):e1000205. PubMed ID: 18833298
[TBL] [Abstract][Full Text] [Related]
32. Mutations in Drosophila DP and E2F distinguish G1-S progression from an associated transcriptional program.
Royzman I; Whittaker AJ; Orr-Weaver TL
Genes Dev; 1997 Aug; 11(15):1999-2011. PubMed ID: 9271122
[TBL] [Abstract][Full Text] [Related]
33. A gradient of epidermal growth factor receptor signaling determines the sensitivity of rbf1 mutant cells to E2F-dependent apoptosis.
Moon NS; Di Stefano L; Dyson N
Mol Cell Biol; 2006 Oct; 26(20):7601-15. PubMed ID: 16954388
[TBL] [Abstract][Full Text] [Related]
34. Retinoblastoma family 2 is required in vivo for the tissue-specific repression of dE2F2 target genes.
Stevaux O; Dimova DK; Ji JY; Moon NS; Frolov MV; Dyson NJ
Cell Cycle; 2005 Sep; 4(9):1272-80. PubMed ID: 16082225
[TBL] [Abstract][Full Text] [Related]
35. Subunit composition determines E2F DNA-binding site specificity.
Tao Y; Kassatly RF; Cress WD; Horowitz JM
Mol Cell Biol; 1997 Dec; 17(12):6994-7007. PubMed ID: 9372931
[TBL] [Abstract][Full Text] [Related]
36. Selective repression of the Drosophila cyclin B promoter by retinoblastoma and E2F proteins.
Mouawad R; Himadewi P; Kadiyala D; Arnosti DN
Biochim Biophys Acta Gene Regul Mech; 2020 Jul; 1863(7):194549. PubMed ID: 32275964
[TBL] [Abstract][Full Text] [Related]
37. A genome-wide RNA interference screen identifies putative chromatin regulators essential for E2F repression.
Lu J; Ruhf ML; Perrimon N; Leder P
Proc Natl Acad Sci U S A; 2007 May; 104(22):9381-6. PubMed ID: 17517653
[TBL] [Abstract][Full Text] [Related]
38. Ectopic expression of dE2F and dDP induces cell proliferation and death in the Drosophila eye.
Du W; Xie JE; Dyson N
EMBO J; 1996 Jul; 15(14):3684-92. PubMed ID: 8670872
[TBL] [Abstract][Full Text] [Related]
39. ORC localization in Drosophila follicle cells and the effects of mutations in dE2F and dDP.
Royzman I; Austin RJ; Bosco G; Bell SP; Orr-Weaver TL
Genes Dev; 1999 Apr; 13(7):827-40. PubMed ID: 10197983
[TBL] [Abstract][Full Text] [Related]
40. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
Li JM; Hu PP; Shen X; Yu Y; Wang XF
Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
